New Research Poster Presentation 3.32
Time-Course of Treatment-Emergent Adverse Events Following Administration of an Extended-Release Methylphenidate Oral Suspension

Thursday, October 24, 2013
Adelaide S. Robb, MD, Child and Adolescent Psychiatry, Children’s National Medical Center, Washington, DC
John A. Gillespie, MD, MBA, EPBU, Pfizer Inc., New York, NY
Heidi W. Belden, PharmD, EPBU, Pfizer Inc., New York, NY
Sally A. Berry, MD, PhD, EPBU, Pfizer Inc., New York, NY
See more of: New Research Posters Session 3
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.